Lawmakers Seek Answers on Rising Insulin Prices
Two lawmakers from opposite sides of the aisle request meetings with insulin makers, insurers, and pharmacy benefit managers to untangle how the price of insulin has surged since its 1921 origins. They note high list prices vs actual costs and the impact on patients, calling for hearings and transparency.